The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| 10X GENOMICS INC | CL A COM | 88025U109 | 214 | 3,427 | SH | DFND | 0 | 3,427 | 0 | ||
| CLOUDFLARE INC | CL A COM | 18915M107 | 113,708 | 4,842,740 | SH | DFND | 4,842,740 | 0 | 0 | ||
| CROWDSTRIKE HLDGS INC | CL A | 22788C105 | 953 | 17,115 | SH | DFND | 0 | 17,115 | 0 | ||
| DOMO INC | COM CL B | 257554105 | 60 | 6,066 | SH | DFND | 0 | 6,066 | 0 | ||
| ELASTIC NV | ORD SHS | N14506104 | 252 | 4,515 | SH | DFND | 0 | 4,515 | 0 | ||
| NGM BIOPHARMACEUTICALS INC | COM | 62921N105 | 19,399 | 1,573,357 | SH | DFND | 1,573,357 | 0 | 0 | ||
| PHATHOM PHARMACEUTICALS INC | COM | 71722W107 | 9,319 | 360,939 | SH | DFND | 360,939 | 0 | 0 | ||
| SLACK TECHNOLOGIES INC | COM CL A | 83088V102 | 432 | 16,100 | SH | DFND | 0 | 16,100 | 0 | ||
| SONOS INC | COM | 83570H108 | 14,991 | 1,767,826 | SH | DFND | 1,767,826 | 0 | 0 | ||
| SPROUT SOCIAL INC | COM CL A | 85209W109 | 48,272 | 3,024,562 | SH | DFND | 3,024,562 | 0 | 0 | ||
| THE REALREAL INC | COM | 88339P101 | 33,251 | 4,743,428 | SH | DFND | 4,743,428 | 0 | 0 | ||
| UBER TECHNOLOGIES INC | COM | 90353T100 | 666 | 23,851 | SH | DFND | 0 | 23,851 | 0 | ||